ROLE OF NEUROMODULATION IN MIGRAINE
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
A New Way to Treat Brain Diseases at Home Using Noninvasive Brain Stimulation
The COVID-19 pandemic has highlighted a need for non-invasive, remote approaches to patient care. Dr. Eric Grigsby, CEO and Founder of Neurovations, and Ana Maiques, CEO and Co-founder of Neuroelectrics, […]
A New Way to Treat Brain Diseases at Home Using Non-Invasive Brain Stimulation
The COVID-19 pandemic has highlighted a needs for non-invasive, remote approaches to patient care. Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home. Join […]
NEUROMODULATION: THE SCIENCE
Through partnership with Neuromodec and the Neural Interfaces Conference (NIC), the Neuromodulation: the Science integrates brain stimulation, imaging, AR/VR wearables, and digital healthcare to provide attendees with relevant and up-to-date insights on emerging science and technologies from bench to bedside and home use.
Preparing Your Re-entry Plan
Download the resources to the webinar and map your future for pain procedures.
Neuromodulation for the COVID-19 Cytokine Storm
Join Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA
for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm
Preparing Your Re-entry Plan
Join Eric J. Grigsby, MD, MBA and NANS Board Member, Stephanie G.
Vanterpool, MD, MBA for a conversation exploring NANS’ new Neuromodulation Device Algorithm – COVID-19.
Dr. Eric Grigsby Recognized for Visionary Leadership in Pain Management
CEO and Founder of Neurovations Honored as Patient Champion NAPA, Calif., October 16, 2019 (Newswire.com) – Dr. Eric Grigsby was awarded the Visionary Leadership Award at the 6th Annual Business of […]